Resources
For the latest in immuno, sign up for our monthly newsletter to be among the first to receive exclusive insights,
in-depth market analyses, and expert articles directly to your inbox
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Vaccines
Using Humanised Mice to Evaluate Vaccine Efficacy
Kymab Ltd presents the utility of mice models for studying human immune response to complex vaccines.
Drug Discovery & Development
iNKT Cells and Their Applications in Immuno-Oncology
The applications of iNKT cells as oncological therapeutics and remedial treatments are almost astoundingly diverse. Their capacity for moderation subject to their intended use makes them suited to a variety of therapeutic functions and applications.
Vaccines
mRNA Therapeutics: Learning from Preclinical Concepts to Ensure Clinical Translatability in Nanomedicinal Approaches
This Commentary article explores the applications of mRNA therapeutics in disease treatment and prevention. The commercial presence of microfluidics technologies has improved process development, and has helped to provide rapid development along with the existence of established formulation principles for vaccines.
Vaccines
Moderna Sues Pfizer and BioNTech over mRNA COVID-19 Vaccines
Why is Moderna suing Pfizer and BioNTech over its COVID-19 vaccine despite recent pledge?
Vaccines
Q & A with Vincent Dewar
We interview Vincent Dewar, Associate Director and Head of Immunoassay Analytical Research Development at GlaxoSmithKline, to learn more about the importance of immunoassays for vaccine development.
Immuno-Oncology
Preclinical Strategies for Combination Immunotherapies
Oncology is almost always oriented towards simultaneous treatment options. We explore why as well as the approach’s unique challenges.
Vaccines
Will Vaccine Manufacturers go into Overdrive this Flu Season?
With influenza expected to make a return this winter, vaccine manufacturers may be facing more demand than usual.
Vaccines
Children in London to be Given Urgent Polio Booster Vaccine
Children between one and nine years old to be given polio jab to curb the spread of the virus throughout the city.
Vaccines
China Warns of New Virus Transmitted by Shrews
How worrying is the new ‘Langya’ virus spreading in China?
Vaccines
Monkeypox Cases in UK Begin to Plateau
Statistics show that the number of people infected with the monkeypox virus is starting to slow down.
Immuno-Oncology
AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development
Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS
Vaccines
European Approval for Monkeypox Vaccine
The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things immuno